What is the treatment for cystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cystitis

For uncomplicated cystitis in women, nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days) is the recommended first-line treatment due to its high efficacy and low resistance rates. 1

First-Line Treatment Options

  1. Nitrofurantoin monohydrate/macrocrystals

    • Dosage: 100 mg twice daily for 5 days
    • Efficacy: 90% clinical cure rate, 92% bacterial eradication rate 1
    • Advantages: Minimal resistance (approximately 2%) and minimal collateral damage 2, 1
  2. Trimethoprim-sulfamethoxazole (TMP-SMX)

    • Dosage: 160/800 mg (double-strength tablet) twice daily for 3 days
    • Use only if:
      • Local resistance rates of uropathogens <20%
      • Not used in previous 3 months
      • Infecting strain is known to be susceptible 2, 1
  3. Fosfomycin trometamol

    • Dosage: 3 g single dose
    • Note: May have inferior efficacy compared to standard short-course regimens 2

Alternative Treatment Options

When first-line agents cannot be used, consider:

  1. Fluoroquinolones (e.g., ciprofloxacin)

    • While highly efficacious, should be reserved for more serious infections due to:
      • Propensity for collateral damage to normal flora
      • FDA warnings about serious side effects
      • Need to preserve for more serious infections 2, 1
    • Use only if fluoroquinolone resistance <10% 1
  2. β-Lactam agents

    • Options: amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil (3-7 days)
    • Generally have inferior efficacy and more adverse effects compared to other UTI antimicrobials 2
    • Should be used only when other recommended agents cannot be used 2

Diagnostic Considerations

  • Urinalysis (dipstick test) to check for indicators of infection
  • Urine culture is not routinely needed for uncomplicated cystitis but should be obtained in:
    • Suspected pyelonephritis
    • Symptoms that don't resolve or recur within 4 weeks after treatment
    • Women with atypical symptoms
    • Pregnant women 1

Monitoring and Follow-up

  • No routine post-treatment urinalysis or cultures needed if symptoms resolve 1
  • If symptoms don't improve within 72 hours, reevaluate with urine culture 1

Special Populations

Pregnant Women

  • Screen for and treat asymptomatic bacteriuria
  • Consider single-dose fosfomycin or standard short-course treatment 1

Postmenopausal Women

  • May benefit from vaginal estrogen replacement
  • Consider continuous antimicrobial prophylaxis when non-antimicrobial measures have been unsuccessful 1

Patients with Renal Impairment

  • Nitrofurantoin is contraindicated in patients with creatinine clearance <30 mL/min 1
  • Fluoroquinolones should be used with caution in patients with GFR <50 mL/min 1
  • Extended treatment duration (7-14 days) may be needed 1

Common Pitfalls to Avoid

  1. Using fluoroquinolones as first-line therapy despite recommendations to reserve them for more serious infections
  2. Prescribing TMP-SMX in areas with high resistance rates (>20%)
  3. Not adjusting therapy for patients with renal impairment
  4. Treating asymptomatic bacteriuria (except in pregnant women)
  5. Performing routine post-treatment cultures in patients whose symptoms have resolved

The treatment of cystitis should be guided by local resistance patterns, patient-specific factors, and antimicrobial stewardship principles to ensure optimal outcomes while minimizing adverse effects and antimicrobial resistance.

References

Guideline

Treatment of Uncomplicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.